Back to Search Start Over

Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein

Authors :
Anne Goffard
Cécile-Marie Aliouat-Denis
Laurence Cocquerel
Jean Dubuisson
Hervé Drobecq
Juliano G Haddad
Jacques Izopet
Jean-Michel Saliou
François Helle
Philip Meuleman
Maliki Ankavay
Jean-Christophe Meunier
Rayan Farhat
Florence Abravanel
Ibrahim M Sayed
Claire Montpellier
Czeslaw Wychowski
André Pillez
Anne Bull
Etienne Brochot
Cocquerel, Laurence
Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL)
Institut Pasteur de Lille
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS)
Universiteit Gent = Ghent University (UGENT)
Assiut University
Morphogénèse et antigénicité du VIH et du virus des Hépatites (MAVIVH - U1259 Inserm - CHRU Tours )
Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Laboratoire Virologie [CHU Toulouse]
Institut Fédératif de Biologie (IFB)
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse]
Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
Unité de Virologie clinique et fondamentale (UVCF)
Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie
Mécanismes de la Tumorigénèse et Thérapies Ciblées - UMR 8161 (M3T)
Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre National de la Recherche Scientifique (CNRS)
This work was supported by the French 'Agence Nationale de la Recherche sur le Sida et les hépatites virales' (ANRS) and the University of Lille. M.A. was supported by a fellowship from the ANRS. P.M. was supported by grants from the Research Foundation Flanders (FWO Vlaanderen), Ghent University (BOF GOA and IRO), and the Belgian State (BELSPO IAP HEPRO-2). I.M.S. was supported with PhD fellowships from the Egyptian Government and Ghent University. J.G.H. was supported by a fellowship from the Lebanese Association for Development.
We thank Sandrine Belouzard, Karin Seron, and Sophana Ung for their technical contribution. We thank Suzanne U. Emerson (National Institutes of Health) and Shoshana Levy (Stanford University) for providing us with reagents. We thank Lydia Linna for proofreading the manuscript.
Source :
Gastroenterology, Gastroenterology, 2017, 154 (1), pp.211-223.e8. ⟨10.1053/j.gastro.2017.09.020⟩
Publication Year :
2018
Publisher :
Elsevier BV, 2018.

Abstract

Comment in : New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay Stack. [Gastroenterology. 2018]; International audience; BACKGROUND & AIMS: Hepatitis E virus (HEV) infection is a major cause of acute hepatitis worldwide. Approximately 2 billion people live in areas endemic for HEV and are at risk of infection. The HEV genome encodes 3 proteins, including the ORF2 capsid protein. Detailed analyses of the HEV life cycle has been hampered by the lack of an efficient viral culture system.METHODS: We performed studies with gt3 HEV cell culture-produced particles and patient blood and stool samples. Samples were fractionated on iodixanol gradients and cushions. Infectivity assays were performed in vitro and in human liver chimeric mice. Proteins were analyzed by biochemical and proteomic approaches. Infectious particles were analyzed by transmission electron microscopy. HEV antigen levels were measured with the Wantaï enzyme-linked immunosorbent assay.RESULTS: We developed an efficient cell culture system and isolated HEV particles that were infectious in vitro and in vivo. Using transmission electron microscopy, we defined the ultrastructure of HEV cell culture-produced particles and particles from patient sera and stool samples. We also identified the precise sequence of the infectious particle-associated ORF2 capsid protein. In cultured cells and in samples from patients, HEV produced 3 forms of the ORF2 capsid protein: infectious/intracellular ORF2 (ORF2i), glycosylated ORF2 (ORF2g), and cleaved ORF2 (ORF2c). The ORF2i protein associated with infectious particles, whereas the ORF2g and ORF2c proteins were massively secreted glycoproteins not associated with infectious particles. ORF2g and ORF2c were the most abundant antigens detected in sera from patients.CONCLUSIONS: We developed a cell culture system and characterized HEV particles; we identified 3 ORF2 capsid proteins (ORF2i, ORF2g, and ORFc). These findings will advance our understanding of the HEV life cycle and improve diagnosis.

Details

ISSN :
01688278, 00165085, and 15280012
Volume :
68
Database :
OpenAIRE
Journal :
Journal of Hepatology
Accession number :
edsair.doi.dedup.....b52d58f45ed7ada3e4816b40ec5928c3
Full Text :
https://doi.org/10.1016/s0168-8278(18)31831-2